138 related articles for article (PubMed ID: 12243822)
1. Interobserver variability leads to significant differences in quantifiers of prostate implant adequacy.
Lee WR; Roach M; Michalski J; Moran B; Beyer D
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):457-61. PubMed ID: 12243822
[TBL] [Abstract][Full Text] [Related]
2. Postimplant analysis of transperineal interstitial permanent prostate brachytherapy: evidence for a learning curve in the first year at a single institution.
Lee WR; deGuzman AF; Bare RL; Marshall MG; McCullough DL
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):83-8. PubMed ID: 10656377
[TBL] [Abstract][Full Text] [Related]
3. The effect of interobserver variability on transrectal ultrasonography-based postimplant dosimetry.
Xue J; Waterman F; Handler J; Gressen E
Brachytherapy; 2006; 5(3):174-82. PubMed ID: 16864069
[TBL] [Abstract][Full Text] [Related]
4. Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy.
Prestidge BR; Bice WS; Kiefer EJ; Prete JJ
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1111-5. PubMed ID: 9539566
[TBL] [Abstract][Full Text] [Related]
5. Effect of prostatic edema on CT-based postimplant dosimetry.
Dogan N; Mohideen N; Glasgow GP; Keys K; Flanigan RC
Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):483-9. PubMed ID: 12023153
[TBL] [Abstract][Full Text] [Related]
6. Impact of postimplant edema on V(100) and D(90) in prostate brachytherapy: can implant quality be predicted on day 0?
Waterman FM; Dicker AP
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):610-21. PubMed ID: 12062604
[TBL] [Abstract][Full Text] [Related]
7. Impact of transrectal ultrasound- and computed tomography-based seed localization on postimplant dosimetry in prostate brachytherapy.
Chew MS; Xue J; Houser C; Misic V; Cao J; Cornwell T; Handler J; Yu Y; Gressen E
Brachytherapy; 2009; 8(2):255-264. PubMed ID: 19213606
[TBL] [Abstract][Full Text] [Related]
8. Comparison of intraoperative ultrasound with postimplant computed tomography--dosimetric values at Day 1 and Day 30 after prostate brachytherapy.
Ohashi T; Yorozu A; Toya K; Saito S; Momma T; Nagata H; Kosugi M; Shigematsu N; Kubo A
Brachytherapy; 2007; 6(4):246-53. PubMed ID: 17959425
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of interobserver differences in postimplant dosimetry following prostate brachytherapy and the efficacy of CT/MRI fusion imaging.
Aoki M; Yorozu A; Dokiya T
Jpn J Radiol; 2009 Nov; 27(9):342-7. PubMed ID: 19943144
[TBL] [Abstract][Full Text] [Related]
10. Effect of edema associated with 131Cs prostate permanent seed implants on dosimetric quality indices.
Kehwar TS; Jones HA; Huq MS; Beriwal S; Benoit RM; Smith RP
Med Phys; 2009 Aug; 36(8):3536-42. PubMed ID: 19746787
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric quantifiers for low-dose-rate prostate brachytherapy: is V(100) superior to D(90)?
Papagikos MA; Deguzman AF; Rossi PJ; McCullough DL; Clark PE; Lee WR
Brachytherapy; 2005; 4(4):252-8. PubMed ID: 16344254
[TBL] [Abstract][Full Text] [Related]
12. Interobserver variability of 3.0-tesla and 1.5-tesla magnetic resonance imaging/computed tomography fusion image-based post-implant dosimetry of prostate brachytherapy.
Watanabe K; Katayama N; Katsui K; Matsushita T; Takamoto A; Ihara H; Nasu Y; Takemoto M; Kuroda M; Kanazawa S
J Radiat Res; 2019 Jul; 60(4):483-489. PubMed ID: 31083713
[TBL] [Abstract][Full Text] [Related]
13. Impact of differences in ultrasound and computed tomography volumes on treatment planning of permanent prostate implants.
Narayana V; Roberson PL; Pu AT; Sandler H; Winfield RH; McLaughlin PW
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1181-5. PubMed ID: 9169829
[TBL] [Abstract][Full Text] [Related]
14. A dynamic model for the estimation of optimum timing of computed tomography scan for dose evaluation of 125I or 103Pd seed implant of prostate.
Yue N; Dicker AP; Corn BW; Nath R; Waterman FM
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):447-54. PubMed ID: 10030274
[TBL] [Abstract][Full Text] [Related]
15. Comparison of MRI-based and CT/MRI fusion-based postimplant dosimetric analysis of prostate brachytherapy.
Tanaka O; Hayashi S; Matsuo M; Sakurai K; Nakano M; Maeda S; Kajita K; Deguchi T; Hoshi H
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):597-602. PubMed ID: 16966002
[TBL] [Abstract][Full Text] [Related]
16. Comparison of MRI pulse sequences in defining prostate volume after permanent implantation.
McLaughlin PW; Narayana V; Drake DG; Miller BM; Marsh L; Chan J; Gonda R; Winfield RJ; Roberson PL
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):703-11. PubMed ID: 12377321
[TBL] [Abstract][Full Text] [Related]
17. Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy.
Stone NN; Hong S; Lo YC; Howard V; Stock RG
Brachytherapy; 2003; 2(1):17-25. PubMed ID: 15062159
[TBL] [Abstract][Full Text] [Related]
18. CT-based postimplant dosimetry of prostate brachytherapy: comparison of 1-mm and 5-mm section CT.
Tanaka O; Hayashi S; Kanematsu M; Matsuo M; Nakano M; Maeda S; Deguchi T; Hoshi H
Radiat Med; 2007 Jan; 25(1):22-6. PubMed ID: 17225049
[TBL] [Abstract][Full Text] [Related]
19. Brachytherapy in patients with small prostate glands.
Loblaw DA; Wallner K; Dibiase S; Russell K; Blasko J; Ellis W
Tech Urol; 2000 Jun; 6(2):64-9. PubMed ID: 10798802
[TBL] [Abstract][Full Text] [Related]
20. The dependence of prostate postimplant dosimetric quality on CT volume determination.
Merrick GS; Butler WM; Dorsey AT; Lief JH
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1111-7. PubMed ID: 10421545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
